Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

Author： Kruidenier L.   Verspaget H. W.  

Publisher： Informa Healthcare

ISSN： 1466-1861

Source： Mediators of Inflammation, Vol.7, Iss.3, 1998-06, pp. : 157-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokines in inflammatory bowel disease

By Beck P. L.   Wallace J. L.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 95-103

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease in Asia

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 436-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory Bowel Disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. : 117-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Altered expression of caspases‐4 and ‐5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 1, 2015-07 ,pp. : 39-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 821-834

John Wiley & Sons Inc

Access to resources Recommend Favorite